Nitrate-Induced Toxicity and Preconditioning. A Rationale for Reconsidering the Use of These Drugs

Journal of the American College of Cardiology

Volumn 52, Issue 4, 2008, Pages 251-254

  Gori, Tommaso ^a,b   Parker, John D ^c  

^a UNIVERSITY OF SIENA   (Italy)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

angina; ischemia; nitroglycerin; preconditioning

Indexed keywords

GLYCERYL TRINITRATE; NITRATE;

ANGINA PECTORIS; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG MECHANISM; DRUG SAFETY; ENDOTHELIAL DYSFUNCTION; HEART FAILURE; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; HEART RATE VARIABILITY; HOMEOSTASIS; HUMAN; LONG TERM CARE; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

ANGINA PECTORIS; ENDOTHELIUM, VASCULAR; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL ISCHEMIA; NITRIC OXIDE; NITRO COMPOUNDS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; STEM CELLS;

EID: 46849092968     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.04.019     Document Type: Review

References (23)

1. Münzel T., Daiber A., and Mulsch A. Explaining the phenomenon of nitrate tolerance. Circ Res 97 (2005) 618-628
2. Gori T., and Parker J.D. The puzzle of nitrate tolerance: pieces smaller than we thought?. Circulation 106 (2002) 2404-2408
3. Gori T., Floras J.S., and Parker J.D. Effects of nitroglycerin treatment on baroreflex sensitivity and short-term heart rate variability in humans. J Am Coll Cardiol 40 (2002) 2000-2005
4. La Rovere M.T., Pinna G.D., Hohnloser S.H., et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 103 (2001) 2072-2077
5. Azevedo E.R., Schofield A.M., Kelly S., and Parker J.D. Nitroglycerin withdrawal increases endothelium-dependent vasomotor response to acetylcholine. J Am Coll Cardiol 37 (2001) 505-509
6. Heitzer T., Just H., Brockhoff C., Meinertz T., Olschewski M., and Munzel T. Long-term nitroglycerin treatment is associated with supersensitivity to vasoconstrictors in men with stable coronary artery disease: prevention by concomitant treatment with captopril. J Am Coll Cardiol 31 (1998) 83-88
7. Thomas G.R., DiFabio J.M., Gori T., and Parker J.D. Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanism. J Am Coll Cardiol 49 (2007) 1289-1295
8. DeMots H., and Glasser S.P. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. J Am Coll Cardiol 13 (1989) 786-795
9. Gori T., Di Stolfo G., Sicuro S., et al. Nitroglycerin protects the endothelium from ischaemia and reperfusion: human mechanistic insight. Br J Clin Pharmacol 64 (2007) 145-150
10. Dawn B., and Bolli R. Role of nitric oxide in myocardial preconditioning. Ann N Y Acad Sci 962 (2002) 18-41
11. Jneid H., Chandra M., Alshaher M., et al. Delayed preconditioning-mimetic actions of nitroglycerin in patients undergoing exercise tolerance tests. Circulation 111 (2005) 2565-2571
12. Kloner R.A., and Jennings R.B. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2. Circulation 104 (2001) 3158-3167
13. Murphy E. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ Res 94 (2004) 7-16
14. Chrysant S.G., Glasser S.P., Bittar N., et al. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris. Am J Cardiol 72 (1993) 1249-1256
15. Parker J.O., Amies M.H., Hawkinson R.W., et al. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group. Circulation 91 (1995) 1368-1374
16. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 343 (1994) 1115-1122
17. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 345 (1995) 669-685
18. Ishikawa K., Kanamasa K., Ogawa I., et al. Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Secondary Prevention Group. Jpn Circ J 60 (1996) 779-788
19. Kanamasa K., Naito N., Morii H., et al. Eccentric dosing of nitrates does not increase cardiac events in patients with healed myocardial infarction. Hypertens Res 27 (2004) 563-572
20. Cohn J.N., Archibald D.G., Ziesche S., et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 314 (1986) 1547-1552
21. Taylor A.L., Ziesche S., Yancy C., et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 351 (2004) 2049-2057
22. Gori T., and Parker J.D. Nitrate tolerance: a unifying hypothesis. Circulation 106 (2002) 2510-2513
23. Dragoni S., Gori T., Lisi M., et al. Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion. Arterioscler Thromb Vasc Biol 27 (2007) 1955-1959